Selv om selve Mesotheliom indikasjonen i seg selv ikke er særlig stor, er det en ODD indikasjon med et “high unmet need”. Jonas Einarsson har tidligere kommunisert at Mesotheliom indikasjonen kan bli en fremtidig prestisje-indikasjon i USA pga 9/11. Symptomer på Mesotheliom påvises som oftest ikke før 20-50 år etter asbest eksponering. Da har gjerne kreften allerede vokst og spredt seg.
Litt mer bakgrunn fra 9/11.
" Malignant mesothelioma has become the latest deadly cancer linked directly to the rescue, recovery and cleanup efforts following the 9/11 terrorist attack on New York City in 2001.
Eighteen years after Manhattan was engulfed in the asbestos-laced, toxic cloud of dust — caused primarily by the World Trade Center destruction — the first death from pleural mesothelioma attributed to 9/11 has been recorded.
Mesothelioma is caused primarily by the inhalation or ingestion of microscopic asbestos fibers, which were part of the toxic mixture unleashed by the collapse and burning of the World Trade Center.
According to the World Trade Center Registry, 410,000 people were exposed to asbestos and a myriad of chemicals in the air that included cement dust, diesel oils, lead, mercury, metals, particulates and a host of other carcinogens.
Exposed were first responders — such as police and firemen — recovery and cleanup workers and volunteers who assisted everywhere.
They also included what the registry calls survivors, those who worked, lived or went to school in the disaster area."
…Og :
" Mesothelioma specialists, such as Stevens in Michigan and thoracic surgeon Dr. Raja Flores at New York’s Mount Sinai Hospital, strongly believe a stream of new cases stemming from 9/11 is coming."
“We’re 18 years out. Maybe we’ll see one here or two there, those who were more susceptible, maybe with a genetic predisposition, or exposed other ways with legacy asbestos,” Flores told The Mesothelioma Center at Asbestos.com. “Once you get to 25 to 30 years out, you’ll start seeing a big spike in cases.”
Jeg vil anta at Merck ser denne trenden.
Dataene til Targovax i Mesotheliom har for meg vært lovende siden dataslipp, men først i dag jeg føler selskapet virkelig har tatt et solid steg med håndfaste mOS/OS data i tillegg.